Alessandro Spina

Pharmaceuticals


European Journal of Risk Regulation 1/2010: pp. 81-82

€ 23,80 (including 19 % tax)


This section updates readers on the latest developments in pharmaceutical law, giving information on legislation and case law on various matters (such as clinical and pre-clinical trials, drug approval and marketing authorisation, the role of regulatory agencies) and providing analysis on how and to what extent they might affect health and security of the individual as well as in industry.

Find out more about EJRR here
  

Shopping cart

 Price Delete
Your cart is currently empty.
Subtotal*
*excl. shipping costs Buy now

EStAL
Journal
Publication frequency: quarterly
Subscription: € 442,-
ISSN 16 19-52 72

Further information

Reading of Intimate Brussels - Living amongst Eurocrats

30 March 2011, 18.30 pm @ European Parliament

For one year, Martin Leidenfrost explored Europe’s capital and wrote fifty personal – tender, alienated, mischievous – portraits.

“Entertaining, amusing, insightful.” The Gap